Avanafil
Back to searchMolecule Structure
Scientific Name
Avanafil
Description of the Drug
Avanafil is a phosphodiesterase-5 (PDE5) inhibitor used to treat erectile dysfunction.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06237
http://www.drugbank.ca/drugs/DB06237
Brand Name(s)
Spedra, Stendra
Company Owner(s)
Metuchen Pharmaceuticals Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Phosphodiesterase 5A | SINGLE PROTEIN | INHIBITOR | CHEMBL1827 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL118799 | |
| DrugBank | DB06237 | |
| PubChem: Thomson Pharma | 15132057 | 14834924 |
| PubChem | 9869929 | |
| LINCS | LSM-45456 | |
| Nikkaji | J2.782.076J | |
| PDBe | E6L | |
| BindingDB | 50036629 | 235766 |
| EPA CompTox Dashboard | DTXSID50186727 | |
| DrugCentral | 4305 | |
| Guide to Pharmacology | 7448 | |
| rxnorm | AVANAFIL | STENDRA |
| PubChem: Drugs of the Future | 125299302 | |
| ChEBI | 66876 | |
| ZINC | ZINC000011677857 |
